| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;36:890.)
© 2000 American Heart Association, Inc.
Colin Johnston - A Celebration |
From the Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY.
Correspondence to Dr Michael Alderman, Albert Einstein College of Medicine, Department of Epidemiology and Social Medicine, 1300 Morris Park Ave, Bronx, NY 10461. E-mail alderman{at}aecom.yu.edu
| Abstract |
|---|
|
|
|---|
Key Words: blood pressure hypertension, sodium dependent sodium, dietary renin-angiotensin system morbidity mortality
| Introduction |
|---|
|
|
|---|
Because ecological studies identified an association of salt intake to blood pressure, it was naturally suspected that an alteration in sodium intake could alter pressure. To test that hypothesis, investigators first explored the effect of change in sodium diet produced by migration on blood pressure. Usually, migrants from an nonindustrialized environment to an urban setting manifested an increase in blood pressure compared with those left behind. Among the myriad of changes associated with migration, it was found that sodium intake generally increased to the higher level ingested by the host cosmopolitan population. Thus, studies of migrants tended to reinforce the view that an increase in sodium intake was responsible for the rise in blood pressure.
Recently, however, findings among the Kuna Indian, initially residents of the San Blas Islands off Panama, have cast doubt on the notion that salt is the factor responsible for the change in blood pressure associated with acculturation.1 Some 50 years ago, when all Kuna people were confined to an island with minimal access to sodium, both sodium intake and lifelong pressures were low. Since then, the same Kuna people have established trade relations with the mainland, and sodium availability increased to the level as consumed by mainland Panamanians. Remarkably, however, these island people, mostly maintaining their traditional cultural pattern, with the exception of increased dietary sodium, retained the pattern of low blood pressures and revealed no tendency for it to rise with age.
| Observational Studies of Sodium and Blood Pressure |
|---|
|
|
|---|
| Experimental Studies of Sodium and Blood Pressure |
|---|
|
|
|---|
Results of these clinical trials have been inconsistent.
This has led to a sequence of meta-analyses designed to
determine the most likely overall effect of dietary salt for a
population. All meta-analyses are limited by the character of
the studies included. Unfortunately, the well-designed and
well-conducted studies involved considerable variation in sodium
consumption, and many were of short duration; nevertheless, the most
rigorous meta-analyses are in general
agreement.4 5 The most recent indicates that among
hypertensive and older subjects, a 3- to 5-mm Hg systolic and
1-mm Hg diastolic change in pressure is associated with
a 75 to 100 mmol/24 hour difference in sodium intake. The effect
on younger and normotensive subjects is less:
2 to 3 mm Hg for
systolic and <1 mm Hg for diastolic. It
would appear that the largest decline is achieved when small groups of
subjects are studied for short periods of time. It has been difficult
to sustain, over periods beyond a year, either the blood pressure or
the sodium restriction in free-living subjects. It should be noted,
however, that a sustained decrease of even a few millimeters of mercury
could, assuming that the method of its achievement produced no harm,
produce more reduction in morbidity and mortality rates than is
currently achieved by treatment of high blood pressure. This
possibility encourages advocates of sodium restriction.
Thus, a large reduction in sodium intake will produce a detectable decline in blood pressure. However, individual responses to the sodium reduction has varied widely in these studies.
| Other Effects of Sodium Restriction |
|---|
|
|
|---|
To determine the net effect of any medical intervention, all of its multiple effects must be considered. Exclusive attention to any oneblood pressure, for examplemay result in having another unwanted effect overlooked. It is impossible to predict what effects might have been produced by changing daily diets with the sole objective of accommodating a halving of sodium intake, from 10 to 5 g.
Thus, medical interventions must be tested for their effects on human health, in addition to determining whether the intervention will be able to produce the targeted effect. For example, in an analogous situation, pregnant women were once advised to limit weight gain during pregnancy to <20 pounds to reduce the risk of rising blood pressure and eclampsia. In fact, this did produce those two desired outcomes. Unfortunately, and unexpectedly, limiting weight gain in pregnancy increased fetal morbidity and mortality rates. Women are no longer advised to limit weight gain in pregnancy.
| Overall Health Effects of Sodium Restriction |
|---|
|
|
|---|
Epidemiological data, in which individual sodium intake and health outcomes are linked, would be the next level of evidence to support the notion that dietary sodium might influence the length or quality of life. Unfortunately, despite intense interest in this issue, regrettably few solid data are available. The Scottish Heart Study, a population-based longitudinal study of 10 000 persons designed to assess the association of a variety of individual characteristics measured at baseline to subsequent morbidity and mortality, did include a questionnaire-derived measure of sodium intake.8 In this study, no association between sodium intake and cardiovascular or all-cause mortality was found.
In a subsequent study of 3000 treated hypertensive patients in whom pretreatment 24-hour sodium intake measured after advice to refrain from excess salt intake for 5 days and baseline PRA were measured, there was a stepwise, significant, and independent relation between level of sodium measured in 24-hour urine and subsequent strokes and heart attacks.9 Although this relation held for the group as a whole, after stratification it was only significant for men, who accounted for 75% of events. Among men, this relation persisted after stratification by age, ventricular mass, and race (Figure). Not unexpectedly, in view of the inverse association of sodium intake and PRA, a good deal of the association of sodium to events was accounted for by level of PRA. Nevertheless, even after accounting for PRA, sodium intake retained an independent association with CVD events.
|
Our group also analyzed the National Heath and Nutrition Examination Survey (NHANES) I epidemiological follow-up data to further explore the relation of sodium intake to CVD and all-cause mortality.10 In this study of 14 000 adults selected randomly to represent the entire US population, sodium intake was estimated on the basis of a 24-hour dietary recall. Again, sodium intake proved to be inversely related to CVD mortality. Those in the lowest quartile of sodium intake were 20% more likely to die of a cardiovascular cause than were those in the highest quartile of sodium consumers.
He and colleagues11 reanalyzed the same NHANES I epidemiological follow-up data. Presumably, although not stated, their analysis of the entire data set did not differ from that already published. Perhaps to explore the suggestion we had previously made that no single sodium intake was likely to be optimal for all people and that heterogeneity as the result of environment, genetics, and behavior is likely to characterize the association of sodium intake to health outcomes, these investigators dissected the data for subgroup assessment. By eliminating participants with prior evidence of CVD and removing a large fraction of cardiovascular end points from consideration, they found that the 28% of subjects in the remaining subgroup, who were obese, expressed a direct relation of sodium to morbid and mortal outcomes. For the 72% of this subset who were not obese, no association of sodium intake to the restricted definition of CVD morbidity and mortality was found (Table). These data are consistent with the expectation that there would be heterogeneity in the relation of sodium intake to health outcomes.
|
Finally, an analysis of the available Multiple Risk Factor Intervention Trial data, available only in abstract, found no relation between sodium intake, estimated by an overnight urine collection, and subsequent CVD events or mortality, although the data appear to suggest a tendency for those consuming the least sodium to have the highest event rates.
Each of these epidemiological studies share the weakness associated with nonexperimental techniques. Unrecognized confounders that influence both the exposure variable and the outcome may have distorted the results. All studies attempt to control for recognized confounders. No matter how diligent, however, this may be imperfect. Moreover, all these studies are based on a single determination of sodium intake. The inevitable intraindividual variation in such measures would tend to diminish any association between an exposure an outcomes. The fact that in 3 of the 5 available studies a significant independent association between salt intake and outcome was found suggests that the available data may underestimate the true strength of the association of sodium intake to morbidity and mortality. In sum, the available data suggest that the association of sodium intake to health outcomes reflected in morbidity and mortality rates is modest and inconsistent. Therefore, on the basis of the existing evidence, it seems highly unlikely that any single dietary sodium intake will be appropriate or desirable for each member of an entire population.
| What Further Data Are Needed |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
I believe that a dietary salt recommendation should reflect knowledge of the sum of its multiple consequences in terms of the quality and duration of human life. Without such knowledge, no single universal dietary recommendation can be scientifically justified.
Received March 27, 2000; first decision July 24, 2000; accepted July 26, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Adiyaman and J. A. Staessen Renin turning full circle as cardiovascular risk factor Eur. Heart J., November 1, 2007; 28(21): 2557 - 2558. [Full Text] [PDF] |
||||
![]() |
P. R. Conlin Eat Your Fruits and Vegetables But Hold the Salt Circulation, October 2, 2007; 116(14): 1530 - 1531. [Full Text] [PDF] |
||||
![]() |
G. Grassi, R. Dell'Oro, G. Seravalle, G. Foglia, F. Q. Trevano, and G. Mancia Short- and Long-Term Neuroadrenergic Effects of Moderate Dietary Sodium Restriction in Essential Hypertension Circulation, October 8, 2002; 106(15): 1957 - 1961. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |